Vaccines

(P-024) Papillomavirus Vaccination and Guillain-barre Syndrome Among Girls: A Population-based Study in Spain

(P-110) Signal Detection of Zoster Vaccine Adverse Event in Elderly Using Korea Adverse Event Reporting System Database (KAERS)

(P-150) Differential Demographic and Clinical Characteristics Between MMR Vaccinated and Unvaccinated Children in South Korea

(P-205) Use and Performance of Brighton Collaboration Case Definitions in Low-middle Income Settings

(P-239) Yellow Fever Vaccine Usage in Three United States Healthcare Databases and Risk of Neurotropic Disease and Viscerotropic Disease in Vaccinees

(P-322) Detecting Signals for the Vaccine-vaccine Interaction Between Pneumococcal Vaccines and Influenza Vaccines Using the Korea Adverse Event Reporting System (KAERS)

(P-325) Comparison of Safety Profiles by Chronic Health Conditions in Korean Adults with Egg-based Inactivated Quadrivalent Influenza Vaccines (QIV, GC3110A)

(P-342) Adverse Events of the COVID-19 Vaccines Reported to the Vaccine Adverse Event Reporting System (VAERS), December 14, 2020 -january 22, 2021

(P-367) The Patterns of Spontaneous Reports of Neurologic, Hematologic, and Immunologic Adverse Events Following Immunization in Korea

(P-423) Safety of COVID-19 Vaccine: Knowledge of Staff at a Medical College in Western Nepal

(P-437) Old Methods and New Data: A near Real-time Plan for Vaccine Surveillance and Signal Detection in the United States

(P-483) Test-negative Designs Applied to COVID-19 Vaccine Effectiveness Assessment: Methodological Challenges